TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06244992: PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

Sponsor: Pyrotech Therapeutics, Inc. · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 68 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$2,238,390

Rescue Site Savings

+$1,492,260

Unlock Full NCT06244992 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06244992 Rescue Dossier →